Page last updated: 2024-10-18

5,6-dihydroorotate and Ovarian Neoplasms

5,6-dihydroorotate has been researched along with Ovarian Neoplasms in 1 studies

4,5-dihydroorotic acid: RN given refers to cpd without isomeric designation; structure
dihydroorotic acid : A pyrimidinemonocarboxylic acid that results from the base-catalysed cyclisation of N(alpha)-carbethoxyasparagine.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cleaveland, ES1
Zaharevitz, DW1
Kelley, JA1
Paull, K1
Cooney, DA1
Ford, H1

Other Studies

1 other study available for 5,6-dihydroorotate and Ovarian Neoplasms

ArticleYear
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
    Biochemical and biophysical research communications, 1996, Jun-25, Volume: 223, Issue:3

    Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, N

1996